ES2344356T3 - Composicion farmaceutica que comprende drospirenona y etinilestradiol. - Google Patents

Composicion farmaceutica que comprende drospirenona y etinilestradiol. Download PDF

Info

Publication number
ES2344356T3
ES2344356T3 ES05777862T ES05777862T ES2344356T3 ES 2344356 T3 ES2344356 T3 ES 2344356T3 ES 05777862 T ES05777862 T ES 05777862T ES 05777862 T ES05777862 T ES 05777862T ES 2344356 T3 ES2344356 T3 ES 2344356T3
Authority
ES
Spain
Prior art keywords
pharmaceutical composition
ethylestradiol
composition including
drospirenone
including drospirenone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES05777862T
Other languages
English (en)
Inventor
Carlos Ariel Sandrone
Jose Mario Sakson
Basaistegui Maria Del Carmen Cajarville
Pomi Jose Daniel Larrosa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Liconsa SA
Original Assignee
Laboratorios Liconsa SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34929434&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2344356(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laboratorios Liconsa SA filed Critical Laboratorios Liconsa SA
Application granted granted Critical
Publication of ES2344356T3 publication Critical patent/ES2344356T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Una composición farmacéutica que comprende drospirenona y etinilestradiol en forma amorfa, adsorbidos sobre un soporte sólido terapéuticamente inerte, en combinación con excipientes farmacéuticamente aceptables, caracterizada porque la composición comprende cantidades medibles del disolvente volátil cloruro de metileno.
ES05777862T 2004-08-09 2005-08-02 Composicion farmaceutica que comprende drospirenona y etinilestradiol. Expired - Lifetime ES2344356T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04103837A EP1625849A1 (en) 2004-08-09 2004-08-09 Pharmaceutical composition comprising drospirenone and ethynylestradiol

Publications (1)

Publication Number Publication Date
ES2344356T3 true ES2344356T3 (es) 2010-08-25

Family

ID=34929434

Family Applications (1)

Application Number Title Priority Date Filing Date
ES05777862T Expired - Lifetime ES2344356T3 (es) 2004-08-09 2005-08-02 Composicion farmaceutica que comprende drospirenona y etinilestradiol.

Country Status (19)

Country Link
US (1) US20090227546A1 (es)
EP (2) EP1625849A1 (es)
JP (1) JP2008509195A (es)
KR (1) KR20070045247A (es)
CN (1) CN101022811B (es)
AR (1) AR045576A1 (es)
AT (1) ATE464053T1 (es)
AU (1) AU2005271206B2 (es)
BR (1) BRPI0513938B8 (es)
CA (1) CA2574997A1 (es)
DE (1) DE602005020694D1 (es)
ES (1) ES2344356T3 (es)
IL (1) IL180899A0 (es)
MA (1) MA28844B1 (es)
NO (1) NO20071297L (es)
RU (1) RU2007108666A (es)
UA (1) UA87513C2 (es)
WO (1) WO2006015956A1 (es)
ZA (1) ZA200702038B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2531929T3 (es) * 2006-12-20 2015-03-20 Teva Women's Health, Inc. Formas de dosificación solidas que se disgregan en la boca que comprenden progestina y métodos para hacer y usar las mismas
HUP0700826A3 (en) 2007-12-20 2010-03-29 Richter Gedeon Nyrt Coated tablet containing drospirenone and process for producing the same
DE102008037025C5 (de) 2008-08-08 2016-07-07 Jesalis Pharma Gmbh Verfahren zur Herstellung kristalliner Wirkstoff-Mikropartikel bzw. einer Wirkstoffpartikel-Festkörperform
KR102023255B1 (ko) 2009-04-01 2019-09-19 바이알 - 포르텔라 앤드 씨에이 에스에이 니트로카테콜 유도체를 포함하는 제약 제제 및 그의 제조 방법
JP5864410B2 (ja) * 2009-04-01 2016-02-17 ノヴィファーマ ソシエテ アノニム ニトロカテコール誘導体を含む医薬製剤及びその製造方法
US10849857B2 (en) * 2010-07-28 2020-12-01 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
US11351122B1 (en) 2010-07-28 2022-06-07 Laboratorios Leon Farma Sa Synthetic progestogens and pharmaceutical compositions comprising the same
AR081670A1 (es) 2010-06-29 2012-10-10 Leon Farma Sa Lab Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
US9603860B2 (en) * 2010-07-28 2017-03-28 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
US20140045900A1 (en) 2011-02-11 2014-02-13 Bial-Portela & Ca, S.A. Administration regime for nitrocatechols
CN102274235B (zh) * 2011-06-27 2013-03-13 潍坊中狮制药有限公司 一种新的避孕药物组合及制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
FR2722984B1 (fr) * 1994-07-26 1996-10-18 Effik Lab Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees
US6027747A (en) * 1997-11-11 2000-02-22 Terracol; Didier Process for the production of dry pharmaceutical forms and the thus obtained pharmaceutical compositions
EP1598069B1 (en) * 1999-08-31 2009-04-22 Bayer Schering Pharma Aktiengesellschaft Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
EE05317B1 (et) * 1999-08-31 2010-08-16 Bayer Schering Pharma Aktiengesellschaft Etinl”stradiooli ja drospirenooni sisaldav farmatseutiline kompositsioon kasutamiseks rasestumisvastase vahendina
DK1361881T3 (da) * 2000-12-14 2006-02-20 Ortho Mcneil Pharm Inc Steroide hormonprodukter og fremgangsmåder til fremstilling heraf
EP1216712A1 (en) * 2000-12-20 2002-06-26 Schering Aktiengesellschaft Cyclodextrin-drospirenone inclusion complexes

Also Published As

Publication number Publication date
ATE464053T1 (de) 2010-04-15
AU2005271206B2 (en) 2009-11-26
KR20070045247A (ko) 2007-05-02
RU2007108666A (ru) 2008-09-20
DE602005020694D1 (de) 2010-05-27
EP1625849A1 (en) 2006-02-15
BRPI0513938B1 (pt) 2018-09-25
BRPI0513938B8 (pt) 2021-05-25
CN101022811A (zh) 2007-08-22
EP1848441A1 (en) 2007-10-31
JP2008509195A (ja) 2008-03-27
ZA200702038B (en) 2008-08-27
NO20071297L (no) 2007-05-02
BRPI0513938A (pt) 2008-05-20
CN101022811B (zh) 2010-09-15
UA87513C2 (ru) 2009-07-27
AU2005271206A1 (en) 2006-02-16
AR045576A1 (es) 2005-11-02
EP1848441B1 (en) 2010-04-14
HK1109579A1 (en) 2008-06-13
WO2006015956A1 (en) 2006-02-16
MA28844B1 (fr) 2007-09-03
US20090227546A1 (en) 2009-09-10
CA2574997A1 (en) 2006-02-16
IL180899A0 (en) 2007-07-04

Similar Documents

Publication Publication Date Title
NO20076613L (no) Farmasoytiske formuleringer og anvendelse derav
ATE540680T1 (de) Pharmazeutische aripiprazol-zusammensetzungen
WO2007072503A3 (en) Combinations for managing inflammation and associated disorders
MX2012003551A (es) Tabletas transformables via oral.
WO2007070632A3 (en) Abuse resistant transmucosal drug delivery device
CL2012001080A1 (es) Dispersión sólida de rifaximina y un portador farmacéuticamente aceptable; composición farmacéutica; uso en el tratarmiento y/o prevención de una infecciíon microbiana que comprende la administración de la dipersión sólida.
MX2010004323A (es) Formas de dosificacion oral que comprenden acetato de licarbazepina.
CL2011000101A1 (es) Compuestos derivados de piridazina sustituida; inhibidores de la señalizacion hedgehog y smo; composicion farmaceutica; y uso para el tratamiento de trastornos o sindromes asociados con enfermedades hiperproliferativas.
IL188744A0 (en) High drug load formulations and dosage forms
NZ598427A (en) Stabilized amorphous forms of imatinib mesylate with cyclodextrin complex
ITTO20040390A1 (it) Composizione, in particolare per uso farmaceutico, ad azione antiossidante, antinfiammatoria ed immunostimolante.
BR0112847A (pt) Uso de uma forma de dosagem sólida
WO2006023644A3 (en) Transdermal drug delivery device with translucent protective film
WO2006131806A3 (en) Multiparticulates comprising low-solubility drugs and carriers that result in rapid drug release
MX2009002356A (es) Composiciones farmaceuticas que comprenden clopidogrel.
MX2019001771A (es) Composición farmacéutica sólida que comprende el sofosbuvir amorfo.
SM200500011B (it) Una composizione farmaceutica antimicobatterica
EA200901387A1 (ru) Фармацевтическая композиция, включающая дезлоратадин
ECSP11010999A (es) Combinación de dosis fija en la forma de una tableta de dos capas o de una sola capa de alisquireno y amlodipina
WO2009061445A3 (en) Use of immunomodulatory compounds for the treatment of disorders associated with endothelial dysfunction
MX2008010233A (es) Composicion de liberacion modificada, que comprende doxofilina.
MX2009008813A (es) Composicion farmaceutica que contiene floroglucinol y paracetamol.
WO2007054904A3 (en) Macrolides as anti-inflammatory agents
PT1499278E (pt) Forma de dosagem farmaceutica de libertacao imediata compreendendo tibolona polimorfa
GEP20135792B (en) Pharmaceutical compositions based on kinin b2 receptor antagonists and corticosteroids, and use of the same